Merck KGaA (OTCMKTS:MKGAF - Get Free Report) shares passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $149.69 and traded as low as $142.08. Merck KGaA shares last traded at $142.08, with a volume of 496 shares changing hands.
Analyst Upgrades and Downgrades
Separately, The Goldman Sachs Group raised shares of Merck KGaA to a "strong-buy" rating in a research report on Thursday, September 19th.
Check Out Our Latest Report on Merck KGaA
Merck KGaA Stock Down 2.3 %
The company has a market capitalization of $18.36 billion, a price-to-earnings ratio of 21.69 and a beta of 0.96. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The firm has a 50 day moving average price of $149.30 and a two-hundred day moving average price of $167.28.
Merck KGaA Company Profile
(
Get Free Report)
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Featured Stories
Before you consider Merck KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.
While Merck KGaA currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
